UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000003671 |
|---|---|
| Receipt number | R000004450 |
| Scientific Title | The study of the incidence, etiology and natural history of adrenal tumor |
| Date of disclosure of the study information | 2010/05/28 |
| Last modified on | 2021/06/15 16:11:13 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The study of the incidence, etiology and natural history of adrenal tumor
Acronym
The study of the incidence, etiology and natural history of adrenal tumor
Scientific Title
The study of the incidence, etiology and natural history of adrenal tumor
Scientific Title:Acronym
The study of the incidence, etiology and natural history of adrenal tumor
Region
| Japan |
Condition
Condition
adrenal tumor
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate that the incidence, etiology and natural history of adrenal tumor.
Basic objectives2
Others
Basic objectives -Others
To investigate that the incidence, etiology and natural history of adrenal tumor.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the incidence, etiology and natural history of adrenal tumor
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
patient who is newly diagnosed as adrenal tumor
Key exclusion criteria
patient who is unsuitable for this study (judged by a doctor)
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Michio |
| Middle name | |
| Last name | Otsuki |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Metabolic Medicine
Zip code
565-0871
Address
2-2 Yamada-oka, Suita, Osaka, Japan
TEL
06-6879-3732
otsuki@endmet.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | Michio |
| Middle name | |
| Last name | Otsuki |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Metabolic Medicine
Zip code
565-0871
Address
2-2 Yamada-oka, Suita, Osaka, Japan
TEL
06-6879-3732
Homepage URL
otsuki@endmet.med.osaka-u.ac.jp
Sponsor or person
Institute
Osaka University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Osaka University Graduate School of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Osaka University Clinical Research Review Committee
Address
2-15 Yamada-oka, Suita, Osaka, Japan
Tel
06-6879-5682
rinri@hp-crc.med.osaka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 05 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
110
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2010 | Year | 03 | Month | 11 | Day |
Date of IRB
| 2010 | Year | 03 | Month | 11 | Day |
Anticipated trial start date
| 2010 | Year | 03 | Month | 11 | Day |
Last follow-up date
| 2021 | Year | 04 | Month | 22 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
the incidence, etiology and natural history of adrenal tumor
Management information
Registered date
| 2010 | Year | 05 | Month | 28 | Day |
Last modified on
| 2021 | Year | 06 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004450
